Abstract
COVID-19, caused by SARS-CoV-2, has resulted in substantial acute morbidity and mortality worldwide. Beyond the acute phase, a growing number of individuals experience persistent or new symptoms, collectively described as post-COVID syndrome or long-COVID, now recognized as part of the post-acute sequelae of SARS-CoV-2 infection (PASC). These conditions pose a significant and ongoing challenge to healthcare systems. Aim. This narrative review aims to summarize current evidence on post-COVID and long-COVID manifestations across multiple organ systems, explore underlying pathophysiological mechanisms, and highlight implications for long-term management and future research. Materials and methods. A comprehensive literature search was conducted using PubMed, Scopus, and Web of Science databases, covering publications from 2020 to 2025, including original research articles, systematic reviews, meta-analyses, clinical cohort studies, and relevant consensus statements. Results. A review of recent literature on clinical and morphological alterations across various organ systems in the late phase after COVID-19 reveals a wide spectrum of pathological states characterized by a heterogeneous clinical course. Such conditions may persist for months, substantially compromising the patients’ quality of life. While it is established that the pathogenesis of post-COVID pathology is multifaceted, it remains to be fully elucidated. Effective clinical management requires a holistic, multidisciplinary strategy focusing on symptom-directed care, early rehabilitation, and psychosocial support. Conclusions. Post-COVID multisystem damage is mediated by diverse pathological mechanisms, such as cellular alteration, chronic inflammation, impaired regeneration, immunopathology, and microvascular dysfunction. These manifestations span multiple systems, affecting the pulmonary, cardiovascular, endocrine, and integumentary systems, as well as the central and peripheral nervous systems. The pathogenesis of long-COVID involves a synergistic interplay between persistent viral reservoirs, cytokine dysregulation with subsequent autoimmunity, autonomic dysfunction, systemic еndotheliopathy and mitochondrial dysfunction. Notably, the protracted treatment regimens required for SARS-CoV-2 can lead to medication-induced pathology, where long-term management strategies themselves may become a source of iatrogenic complications.